Dr Hellena Habte-Asres's Avatar

Dr Hellena Habte-Asres

@drhellena1

Multi-Award-Winning Researcher in Diabetes & CKD | Clinical Academic Nurse & Epidemiologist | Advancing Innovation & Data-Driven Solutions to Improve Outcomes & Patient Experience.

258
Followers
112
Following
12
Posts
11.11.2024
Joined
Posts Following

Latest posts by Dr Hellena Habte-Asres @drhellena1

The Novo Nordisk UK Research Foundation | NNUKRF

UK based HCPs allied to medicine working in diabetes, funds are available to support your professional development and patient benefit. Clinical Project funding up to Β£5000, UK based training and education funding and conference attendance.
Details and deadlines go to www.nnukrf.org.uk

08.10.2025 08:14 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Honoured to be named the winner of of the National BAME Health & Care Award πŸ† – Pioneering Health Research of the Year 2025. Sorry I couldn’t be there in person, but deeply grateful to colleagues, patients & PPIE partners who make this work possibleπŸ™πŸΎ

26.09.2025 08:25 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Bringing Care Together: The Role of Diabetes Kidney Nurses This article explains the important role of a diabetes renal nurse (DRN) a specialist nurse who looks after people living with both diabetes and chronic kidney disease (CKD). These two conditions are...

link.growkudos.com/1e74z204ykg

13.06.2025 12:36 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library Click on the article title to read more.

Publication Alert πŸ“’

"Beyond vision: The emotional toll of advanced diabetic retinopathy" πŸ§ πŸ‘οΈ

We spotlight the emotional impact of vision-threatening DR β€” too often overlooked in care.πŸ‘‡πŸΎ

doi.org/10.1111/dme....

@eye-surgeon-eve.bsky.social @crosbynwaobi.bsky.social

27.05.2025 08:57 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Workforce and patient safety: primary and community care co-ordination for people with long-term conditions This is the fourth of five investigation reports that consider how working conditions in the NHS can be optimised to support patient safety, while maintaining and improving staff wellbeing.

New report from UK Healthcare Services Safety Investigations Body (HSSIB): People with long term conditions are being harmed because care is fragmented and care coordinator roles are suboptimal. #healthpolicy #medsky

www.hssib.org.uk/patient-safe...

11.04.2025 06:47 πŸ‘ 83 πŸ” 27 πŸ’¬ 4 πŸ“Œ 0
Preview
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library Aims Diabetes mellitus remains a prevalent condition worldwide and a significant risk factor for atherosclerotic cardiovascular disease. Recent evidence suggests the use of glucose-lowering therapie.....

πŸ“£Team output led by Dr Usman Shah from the University of Lincoln. 'Optimisation of care among patients with diabetes mellitus & acute coronary syndrome through a specialised cardiodiabetes serviceβ€”A registry study'. πŸ‘‡ πŸ‘‡ #Diabetes #Cardiovascular
onlinelibrary.wiley.com/doi/full/10....

03.04.2025 17:25 πŸ‘ 4 πŸ” 3 πŸ’¬ 1 πŸ“Œ 0

A new publication has been published in collaboration with Breakthrough T1D UK and Diabetes UK to identify six key research and healthcare priorities to tackle diabetic kidney disease (#DKD).

Read more: www.kidneyresearchuk.org/2025/03/05/u...

#Diabetes #KidneyDisease

05.03.2025 12:08 πŸ‘ 4 πŸ” 2 πŸ’¬ 0 πŸ“Œ 1
Post image Post image Post image Post image
02.03.2025 18:48 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Great two days at #DUK2025!

Loved catching up with colleagues & chairing a session 🎀. A highlight was Prof. Wheeler discussing our integrated diabetes care model for people with advanced CKD in NCL πŸ₯πŸ’™.

Grateful for the inspiring conversationsβ€”excited to keep the momentum going!

02.03.2025 18:48 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Preview
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library Click on the title to browse this issue

Our special issue for DiabeticMedicine entitled 'From Bench to Bedside: An integrated and multi-disciplinary approach to tackling diabetic kidney disease' is available online now. πŸ‘‡πŸ‘‡ #KidneyDisease #Diabetes #NephSky #KidneyResearch #Diabetes #CardioSky

onlinelibrary.wiley.com/toc/14645491...

16.01.2025 16:29 πŸ‘ 11 πŸ” 7 πŸ’¬ 1 πŸ“Œ 2
Preview
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

Great read to start 2025 #GLP1 #semaglutide #diabetes #diabetesuk #cardiorenal #GLP1RA
www.thelancet.com/journals/lan...

02.01.2025 17:21 πŸ‘ 9 πŸ” 5 πŸ’¬ 0 πŸ“Œ 1
Diabetic kidney disease: the four pillars of therapy | Medicine Today

Diabetic kidney disease: the four pillars of therapy πŸ‘©β€πŸ”¬πŸ₯ΌπŸ§ͺπŸ‘¨β€πŸ”¬ #Diabetes #Kidneydisease #Cardiovascular #SGLT2i #GLP-1 #NelhSky #CardioSky πŸ‘‡πŸ‘‡πŸ‘‡

medicinetoday.com.au/mt/2024/dece...

28.12.2024 21:40 πŸ‘ 9 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0

Glad you two met! We’d love to have you in London, @drmccamey.bsky.social! Super excited! πŸŽ‰βœ¨

22.12.2024 14:10 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENA... Aims/hypothesis Our aim was to assess sex differences in the efficacy of angiotensin receptor blockers (i.e. losartan and irbesartan) on kidney and cardiovascular outcomes in individuals with type 2 d...

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes & diabetic kidney disease: post hoc analyses of the RENAAL & IDNT trials #NephSky #CardioSky #KidneyDisease #diabetes πŸ‘‡πŸ‘‡

link.springer.com/article/10.1...

16.12.2024 08:21 πŸ‘ 10 πŸ” 3 πŸ’¬ 1 πŸ“Œ 1
Fuchsia and purple ombrΓ© background with the wording 'What are the symptoms of kidney disease?' in bold white writing. At the bottom is an arrow prompting the user to go on to the next image.

Fuchsia and purple ombrΓ© background with the wording 'What are the symptoms of kidney disease?' in bold white writing. At the bottom is an arrow prompting the user to go on to the next image.

Fuchsia and purple ombrΓ© background with the wording 'Kidney disease is often referred to as the β€˜silent killer’. Early stages of kidney disease are not easy to detect and usually picked up on routine test e.g. blood or urine test.' Another arrow sits at the bottom right.

Fuchsia and purple ombrΓ© background with the wording 'Kidney disease is often referred to as the β€˜silent killer’. Early stages of kidney disease are not easy to detect and usually picked up on routine test e.g. blood or urine test.' Another arrow sits at the bottom right.

Fuchsia and purple ombrΓ© background with the wording 'However, signs for advanced kidney disease are:' and lists 16 bullet points including dry skin, itching, muscle cramps, shortness of breath and bone or joint pain. An arrow sits at the bottom of the page.

Fuchsia and purple ombrΓ© background with the wording 'However, signs for advanced kidney disease are:' and lists 16 bullet points including dry skin, itching, muscle cramps, shortness of breath and bone or joint pain. An arrow sits at the bottom of the page.

Fuchsia and purple ombrΓ© background with the wording "If you are experiencing any of these symptoms, arrange an appointment with your GP." End of images.

Fuchsia and purple ombrΓ© background with the wording "If you are experiencing any of these symptoms, arrange an appointment with your GP." End of images.

What better way to kick off our journey here than by raising awareness about kidney health? Let’s start by highlighting the main symptoms of kidney disease.

Early diagnosis is key to managing and slowing progression of kidney failure.

For more information on symptoms, click here: bit.ly/3z7fsVi

09.12.2024 11:45 πŸ‘ 6 πŸ” 2 πŸ’¬ 1 πŸ“Œ 0
Post image

It's #GIVINGTUESDAY!!! Help us reach the goal of $3,000! Every amount counts. Unable to give? Consider sharing this post, our facebook fundraiser, and the link to our donation page: www.dnpsofcolor.org/donate or Facebook fundraiser:
www.facebook.com/donate/13005...
Thank you!

03.12.2024 12:42 πŸ‘ 2 πŸ” 2 πŸ’¬ 1 πŸ“Œ 1
Preview
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trial πŸ‘©β€πŸ”¬πŸ₯ΌπŸ§ͺ #cardioSky #NephSky #kidneyDisease #Diabetes #Nephropathy #CKD #MedSky #GLP-1 πŸ‘‡πŸ‘‡πŸ‘‡

www.thelancet.com/journals/lan...

27.11.2024 19:31 πŸ‘ 12 πŸ” 4 πŸ’¬ 0 πŸ“Œ 1
Preview
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants In most countries, especially in low-income and middle-income countries, diabetes treatment has not increased at all or has not increased sufficiently in comparison with the rise in prevalence. The bu...

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants πŸ‘©β€πŸ”¬πŸ”¬πŸ₯Ό #Diabetes #Type1diabetes #Type2diabetes #MedSky #Lancet
Full details πŸ‘‡
www.thelancet.com/journals/lan...

26.11.2024 18:30 πŸ‘ 14 πŸ” 6 πŸ’¬ 0 πŸ“Œ 0
Preview
Young adult-onset type 2 diabetes heralds a poor prognosis Younger-onset type 2 diabetes is rapidly increasing in prevalence, with the majority presenting in adulthood aged 18–39 years.1 This change in diabetes topography presents a challenge to health-care p...

Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) #diabetes #T2DM #type2diabetes #MedSky πŸ‘‡πŸ‘‡

www.thelancet.com/journals/lan...

27.11.2024 13:46 πŸ‘ 3 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Thrilled to be speaking at the upcoming Diabetes Africa Forum where we’ll be tackling vital issues in eye and kidney health in Black communities πŸ‘οΈπŸ©ΊπŸ«

I’ll be joined by an incredible panel: Prof @crosbynwaobi.bsky.social, Dr Janaka Karalliedde @eye-surgeon-eve.bsky.social

27.11.2024 10:03 πŸ‘ 6 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
The Effectiveness of MyDiaMate, a Self-guided Web-based App for Mental Health in Type 1 Diabetes: a Multinational Randomized Controlled Trial MyREMEDY (MyDiaMate for REMission of Elevated Diabetes Distress in tYpe 1 diabetes).

πŸ“’ Adults with Type 1 Diabetes: Join the #MyREMEDY study testing MyDiaMate, a web-based self-help programme to improve mental health.

Available in πŸ‡¬πŸ‡§πŸ‡³πŸ‡±πŸ‡©πŸ‡ͺπŸ‡ͺπŸ‡Έ, it covers stress, low mood, fatigue & more.

Learn moreπŸ‘‡πŸΎ

www.kcl.ac.uk/research/myr...
πŸ“© MyREMEDY@kcl.ac.uk

25.11.2024 18:46 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Happy Thanksgiving! My choice of dessert will be Tropical Fruit Salad with Lime and MintπŸ‘ŒπŸΎ

25.11.2024 13:40 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Thank you for sharing this. It’s so important to honour your own needs during this time. Those who truly care will understand and support you as you prioritise yourself. Sending you strength and kindness ❀️

24.11.2024 15:22 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Preview
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patie... BACKGROUND: Sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and the nonsteroidal mineralocorticoid receptor antagonist (ns-MRA) finerenone all...

Estimated Lifetime Cardiovascular, Kidney, & Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, & Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes & Albuminuria πŸ‘©β€πŸ”¬πŸ₯Ό #NephSky #CardioSky

πŸ‘‡πŸ‘‡πŸ‘‡
www.ahajournals.org/doi/10.1161/...

22.11.2024 09:00 πŸ‘ 7 πŸ” 4 πŸ’¬ 0 πŸ“Œ 0
Preview
Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes - Diabetologia Aims/hypothesis Prediabetes (HbA1c 39–47 mmol/mol [5.7–6.4%] or fasting glucose 5.6–6.9 mmol/l) is associated with elevated risks of microvascular and macrovascular complications. It is unknown to wha...

Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes πŸ‘©β€πŸ”¬πŸ₯ΌπŸ”¬πŸ§ͺ. #CardioSky #NephSky #Cardiovascular #cardiorenal #diabetes

@diabetologiajnl.bsky.social πŸ‘‡πŸ‘‡πŸ‘‡

link.springer.com/article/10.1...

21.11.2024 12:59 πŸ‘ 8 πŸ” 6 πŸ’¬ 0 πŸ“Œ 0
Home Compassionomics provides the evidence that one simple tool, compassion, can affect not only the outcomes for our patients, but also the financial health of our…

One of my favourite books. Packed with evidence that compassion is good for others and good for you. www.compassionomics.com

19.11.2024 07:15 πŸ‘ 3 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...

πŸ“£Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity πŸ‘‡πŸ‘‡ #cardiovascular #cardiosky #Obesity #diabetes #GLP-1 #heartfailure

www.nejm.org/doi/full/10....

16.11.2024 15:18 πŸ‘ 9 πŸ” 4 πŸ’¬ 1 πŸ“Œ 0

πŸ–πŸΎ

16.11.2024 13:09 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Thank you, Gemma πŸ₯°

15.11.2024 20:26 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0